Literature DB >> 15645301

Analysis of the interactions of ribonuclease inhibitor with kanamycin.

Zhanli Wang1, Liangren Zhang, Jingfen Lu, Lihe Zhang.   

Abstract

The interaction of ribonuclease inhibitor (RI) with kanamycin was studied by molecular modeling. The preliminary binding model was constructed using the Affinity module of the Insight II molecular modeling program and the key residues involved in the combination of RI binding to kanamycin were determined. Meanwhile, we determined relevant surface characteristics determining the interaction behavior. The modeling results indicated that electrostatic interactions and H-bond forces may work as major factors for the molecular interaction between kanamycin and RI. The above results are useful for elucidating the molecular principles upon which the selectivity of a kanamycin is based. The quartz-crystal microbalance (QCM) is a new method usually used to monitor the binding function of macromolecules with samples online in a flow-injection analysis (FIA) system. The experimental results demonstrate that kanamycin has an extraordinary affinity to the basic protein RI, and our result is consistent with the molecular modeling results. These principles can in turn be used to study the molecular recognition mechanism and design a mimic of kanamycin for the development of new RI binders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645301     DOI: 10.1007/s00894-004-0229-2

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  12 in total

1.  Basic homopolyamino acids, histones and protamines are potent antagonists of angiogenin binding to ribonuclease inhibitor.

Authors:  M Moenner; M Chauvière; P Chevaillier; J Badet
Journal:  FEBS Lett       Date:  1999-01-29       Impact factor: 4.124

2.  Specific binding of aminoglycosides to a human rRNA construct based on a DNA polymorphism which causes aminoglycoside-induced deafness.

Authors:  K Hamasaki; R R Rando
Journal:  Biochemistry       Date:  1997-10-07       Impact factor: 3.162

3.  Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.

Authors:  A C Papageorgiou; R Shapiro; K R Acharya
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 4.  Cytotoxic ribonucleases: molecular weapons and their targets.

Authors:  Alexander A Makarov; Olga N Ilinskaya
Journal:  FEBS Lett       Date:  2003-04-10       Impact factor: 4.124

Review 5.  Structure and action of mammalian ribonuclease (angiogenin) inhibitor.

Authors:  F S Lee; B L Vallee
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1993

6.  A structural basis of the interactions between leucine-rich repeats and protein ligands.

Authors:  B Kobe; J Deisenhofer
Journal:  Nature       Date:  1995-03-09       Impact factor: 49.962

7.  Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.

Authors:  B Kobe; J Deisenhofer
Journal:  J Mol Biol       Date:  1996-12-20       Impact factor: 5.469

8.  Protein chemical and kinetic characterization of recombinant porcine ribonuclease inhibitor expressed in Saccharomyces cerevisiae.

Authors:  A M Vicentini; B Kieffer; R Matthies; B Meyhack; B A Hemmings; S R Stone; J Hofsteenge
Journal:  Biochemistry       Date:  1990-09-18       Impact factor: 3.162

9.  Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production.

Authors:  M L Zapp; S Stern; M R Green
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

10.  Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats.

Authors:  B Kobe; J Deisenhofer
Journal:  Nature       Date:  1993 Dec 23-30       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.